New Topical Treatment for Atopic Dermatitis

New Topical Treatment for Atopic Dermatitis

José Miguel Ingelmo Calvo (1), José Ruiz Cobo (2), Mohamed Farouk Allam (3)

1. Department of Plastic Surgery, Hospital HM Malaga, Spain.

2. Distrito Sanitario Costa del Sol, SUAP Torremolinos, Spain.

3. Department of Family Medicine, Faculty of Medicine, Ain Shams University, Egypt.

European Journal of Medical and Health Sciences 2024;6(2):17-19.

DOI: 10.24018/ejmed.2024.6.2.2067

 

Abstract

The primary approach for managing atopic dermatitis (AD) involves the use of topical corticosteroids as the first-line treatment.While high-potency topical corticosteroids have shown to be effective, they come with an increased risk of local and, rarely, systemic adverse effects. Additionally, patients often experience a relapsing and remitting course. A revolutionary topical treatment for psoriasis and AD has recently received patent approval from the Spanish Ministry of Industry, Trade, and Tourism. This innovative treatment, presented in the form of a lotion, includes a combination of clobetasol, papaverine hydrochloride, spironolactone, a milk-peptide complex, and propylene glycol. An 18-year-old female presented with AD on the back of her neck and scalp. The patient had no significant past medical history and primarily complained of intense pruritus in the AD lesions. The patient received guidance to apply our recently patented lotion, Psorisbye, once a day for 5 days. In total, 50 ml of Psorisbye was utilized over 4 days. On the fifth day, the patient underwent an examination at the outpatient clinic. The patient reported a significant improvement in pruritus sensations and observed a reduction in scaled lesions. Upon evaluating our patient, a comparison of the lesions before and after applying the topical treatment for 4 days revealed a notable improvement in the SCORAD index, decreasing from 49.95 to 0. While the results of Psorisbye in this case show promise, it is crucial to conduct further studies with larger sample sizes and extended follow-up periods to validate the findings presented in our case report.

 

Keywords: Atopic dermatitis, SCORAD, SCORing Atopic Dermatitis, Topical treatment.

 

Calvo JMI, Cobo JR, Allam MF (2024). New Topical Treatment for Atopic Dermatitis. European Journal of Medical and Health Sciences, 6(2), 17–19.

 

https://www.ej-med.org/index.php/ejmed/article/view/2067